Finally, to further probe clinical relevance, we confirmed that increased levels of MPO+CD163−P2Y12−CD68+ macrophages were associated with prolonged survival using our balanced glioblastoma cohort (Extended Data Fig. 10i). This evidence concerns the gene MPO and glioblastoma.